Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
B-FLEXION
Geneva, Geneva, Switzerlandbflexion.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
B-FLEXION is a private investment firm with a strong heritage in life sciences and healthcare. It manages direct holdings and investments in operating businesses across biopharma, diagnostics, healthcare services, and digital health. Recent notable activity includes the sale of Boston Pharmaceuticals' lead asset efimosfermin alfa (a phase III-ready therapy for steatotic liver disease) to GSK for up to $2 billion[7]. The group also owns Affidea (advanced diagnostic imaging/cancer care), Stallergenes Greer (allergy immunotherapy), and has invested in Paratek Pharmaceuticals (antibiotics)[2][6][7].
- Therapeutic areas
- GastroenterologyImmunologyOncology
- Modalities
- BiologicsSmall molecule drugsadvanced therapiesDevice / Service provider model
- Industry
- Investors
02
Partnerships
Novo Holdings A/S co-acquisition of Paratek Pharmaceuticals [6]GSK acquisition of Boston Pharma’s lead asset [7]
Beyond the preview
Go deeper on B-FLEXION.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on B-FLEXION.